The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 170.20
Bid: 169.60
Ask: 170.20
Change: 0.00 (0.00%)
Spread: 0.60 (0.354%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 170.20
FORT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

25 Nov 2021 07:00

RNS Number : 5078T
Forterra plc
25 November 2021
 

25 November 2021

FORTERRA PLC

Trading Update: Continued Strong Performance

Forterra plc, a leading UK producer of manufactured masonry products, provides this trading update covering the four months ended 31 October 2021 (the "period").

Headlines

· Strong trading performance in the period with brick sales volumes up 6% vs 2019 leaving YTD brick sales volumes in line with 2019

· Significant cost inflation experienced across a range of categories including energy, raw materials and transportation. c90% of energy requirement secured for remainder of the year

· Concrete product selling price increases to recover cost inflation have already been achieved with significant brick price increases secured from 1 January 2022

· Accordingly, we expect to deliver a 2021 result in line with management's expectations

· Strong market demand has meant that inventory levels remain at very low levels

· Short term impact on margins experienced due to cost inflation in 2021, but selling price increases are expected to benefit margins in 2022

· Positive market demand dynamics looking into 2022 although business remains broadly capacity constrained until Desford brick factory commissioning

· Around 60% of total energy requirements secured for 2022 with c85% secured for Q1 when risk of volatility is greatest

· Desford and Wilnecote expansion projects progressing according to plan with commissioning of Desford expected in Q4 2022, within £95m budget

Stephen Harrison, Chief Executive of Forterra plc commented:

"The strong trading seen in the both the housebuilding and repair maintenance and improvement (RM&I) markets in first half of the year continued into the second half. As expected, we encountered significant pressures across our supply chain in the period, although, due to the agility of our operational management, we have been successful in limiting any disruption. We also experienced meaningful input cost inflation, which has had a short-term impact on margins, however we are mitigating this through significant selling price increases. Notwithstanding these factors, we continue to anticipate delivering a full year result in line with management's expectations, with higher than expected revenues offsetting the increased cost base.

"Heading into 2022 we are optimistic about the continuing buoyant demand for our products, underpinned by favourable market fundamentals. With the brick capacity uplift provided by the new Desford brick factory now only a year away, and with the Wilnecote project increasing our presence in the commercial and specification market from 2023, we are confident that Group performance will continue to strengthen."

 

ENQUIRIES

Forterra plc +44 1604 707 600

Stephen Harrison, Chief Executive Officer

Ben Guyatt, Chief Financial Officer

FTI Consulting +44 203 727 1340

Richard Mountain / Nick Hasell

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBLBDBDSDDGBS
Date   Source Headline
3rd Aug 20212:49 pmRNSEmployee Benefit Trust Share Purchase
29th Jul 20217:56 amRNSProgressive publishes new research
29th Jul 20217:00 amRNSHalf-year Report
13th Jul 20216:03 pmRNSDirector/PDMR Shareholding
5th Jul 202111:22 amRNSEmployee Benefit Trust Share Purchase
15th Jun 20219:56 amRNSDirector/PDMR Shareholding
7th Jun 20219:24 amRNSEmployee Benefit Trust Share Purchase
27th May 20213:45 pmRNSDirector/PDMR Shareholding
18th May 20213:45 pmRNSAnnual General Meeting 2021 Results
18th May 202110:28 amRNSProgressive publishes new research
18th May 20217:00 amRNSTrading Statement
6th May 20217:00 amRNSEmployee Benefit Trust Share Purchase
30th Apr 20214:07 pmRNSHolding(s) in Company
30th Apr 20211:11 pmRNSGrant under Performance Share Plan
9th Apr 20213:46 pmRNSDirector/PDMR Shareholding
9th Apr 202110:56 amRNSHolding(s) in Company
9th Apr 20217:00 amRNSAnnual Report 2020 and Notice of AGM 2021
8th Apr 20213:31 pmRNSEmployee Benefit Trust Share Purchase
1st Apr 202110:59 amRNSDirector/PDMR Shareholding
30th Mar 20211:14 pmRNSDirector/PDMR Shareholding
25th Mar 20212:41 pmRNSDirector/PDMR Shareholding
22nd Mar 20213:55 pmRNSDirector/PDMR Shareholding
11th Mar 20217:00 amRNSDirector/PDMR Shareholding
9th Mar 20217:00 amRNS2020 FULL YEAR RESULTS
4th Mar 20217:24 amRNSHolding(s) in Company
3rd Mar 202110:36 amRNSHolding(s) in Company
2nd Mar 20217:00 amRNSEmployee Benefit Trust Share Purchase
17th Feb 20213:16 pmRNSHolding(s) in Company
15th Feb 20217:00 amRNSDirector/PDMR Shareholding
8th Feb 20212:16 pmRNSDirector/PDMR Shareholding
2nd Feb 20214:17 pmRNSEmployee Benefit Trust Share Purchase
1st Feb 20214:48 pmRNSDirector/PDMR Shareholding
28th Jan 202112:38 pmRNSHolding(s) in Company
27th Jan 20213:40 pmRNSHolding(s) in Company
26th Jan 20218:15 amRNSProgressive publishes new research
26th Jan 20217:00 amRNSTrading Statement
6th Jan 20217:21 amRNSEmployee Benefit Trust Share Purchase
6th Jan 20217:21 amRNSDirector/PDMR Shareholding
4th Jan 20219:29 amRNSHolding(s) in Company
8th Dec 20202:28 pmRNSEmployee Benefit Trust Share Purchase
27th Nov 20207:00 amRNSEmployee Benefit Trust Share Purchase
24th Nov 20201:00 pmRNSEmployee Benefit Trust Share Purchase
24th Nov 20208:24 amRNSProgressive publishes new research
24th Nov 20207:00 amRNSTrading Statement
5th Nov 20205:09 pmRNSHolding(s) in Company
9th Oct 20203:45 pmRNSGrant of Options under 2020 SAYE Scheme
18th Sep 202010:12 amRNSGrant under Performance Share Plan
18th Sep 20209:40 amRNSHolding(s) in Company
14th Sep 20201:50 pmRNSProgressive publishes new research
14th Sep 20209:05 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.